The Frontiers of Biotechnology Lecture Series
"Improving Human Health through Translational Research"
Peter S. Kim, Ph.D., is a structural biologist known for discovering how
proteins cause membranes to fuse, a central feature of all life. He has
designed novel compounds that stop membrane fusion by the AIDS virus,
thereby preventing it from infecting cells.
Dr. Kim was appointed president of Merck & Co.'s Merck Research Laboratories
(MRL) on January 1, 2003 and he is responsible for all of Merck's drug and
vaccine discovery and development activities. Previously, Dr. Kim served as
MRL's executive vice president of research and development, from February 1,
2001, to December 31, 2002.
Prior to joining Merck, Dr. Kim was a professor of biology at Massachusetts
Institute of Technology (MIT). He was also a member of the Whitehead
Institute and an investigator of the Howard Hughes Medical Institute. Dr.
Kim also served as a member of the National Institutes of Health (NIH)
Advisory Committee to develop an AIDS vaccine.
Dr. Kim received his undergraduate education at Cornell University,
graduating with distinction in chemistry. He received his Ph.D. in
biochemistry from Stanford University in 1985. While at Stanford, he was
also a Medical Scientist Training Program Fellow.
His work has earned him numerous awards including the National Academy of
Sciences Award in Molecular Biology, the Eli Lilly Award in Biological
Chemistry, the Hans Neurath Award of the Protein Society, and the Samsung
Foundation Ho-Am Prize in Basic Science.
Dr. Kim currently is a member of the Board of Directors of Fox Chase Cancer
Center and the Whitehead Institute for Biomedical Research. He also serves
as a member of the Council of the Institute of Medicine.
Dr. Kim was elected a member of the National Academy of Sciences in 1997,
and was elected a member of the Institute of Medicine in 2000.
> Previous Biotechnology Lectures